UPDATE 1-Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 mln By: Reuters: Company News December 26, 2019 at 23:40 PM EST * Deal consists of $120 mln upfront, rest in milestone payments Read More >> Related Stocks: Boundless Bio Inc